Venturi Masks - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The venturi masks market size was valued at USD 2.51 billion in 2025 and is estimated to grow from USD 2.71 billion in 2026 to reach USD 3.95 billion by 2031, at a CAGR of 7.86% during the forecast period (2026-2031). This report is Segmented by Product Type (Single, Multi, Adjustable, Pediatric, Adult), Material Type (PVC, Silicone, Rubber, Others), Oxygen Flow Rate (Low, Medium, High, Others), Application (COPD, Asthma, Pneumonia, Aerosol, and More), End User (Hospitals, Homecare, Ascs, Others), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Venturi Masks Market Trends and Insights

Rising Prevalence of COPD and Other Chronic Respiratory Diseases

COPD remains a central demand driver for the Venturi masks market because it requires controlled oxygen administration during exacerbations. The World Health Organization identified COPD as the third leading cause of death worldwide, with 3.4 million deaths reported for 2023. A 2025 CHEST study placed direct medical costs associated with COPD at USD 778.66 billion in 2025 and projected USD 862.42 billion by 2050. The same research estimated 456 million annual COPD exacerbations in 2025, creating repeated treatment events where controlled oxygen equipment may be required. Guidance for COPD care commonly targets oxygen saturation between 88% and 92%, which supports the clinical use of air-entrainment masks rather than uncalibrated oxygen delivery. Aging populations in East Asia, North America, and Europe extend this need beyond emergency treatment and into chronic respiratory care pathways.

Expansion of Home-Based Oxygen Therapy

Home-based oxygen therapy is expanding the number of care settings that may procure disposable Venturi masks. The shift reduces pressure on acute facilities when stable patients can receive monitored respiratory care outside hospitals. In the United States, H.R. 2902, the Supplemental Oxygen Access Reform Act of 2025, sought to exclude oxygen from a competitive-bidding cycle. The proposed legislation shows that reimbursement policy remains important to the availability of home oxygen supplies. The Venturi masks market can benefit when providers maintain adequate access to respiratory consumables, but lower reimbursement may limit provider capacity. Homecare Settings are forecast to grow at 9.55% CAGR through 2031, which indicates that suppliers need channel strategies suited to care agencies, distributors, and patients as well as hospitals.

Availability of Nasal Cannulas, High-Flow Nasal Cannulas, and Non-Invasive Ventilation

High-flow nasal cannula and non-invasive ventilation systems constrain demand in some higher-acuity use cases. A 2024 multicenter randomized study compared high-flow nasal cannula, non-invasive ventilation, and Venturi masks in postoperative hypoxemia. The study found no statistically significant difference in P/F ratio improvement among the three modalities. Hospitals may still select high-flow systems because they offer a different patient interface and fit wider respiratory-care platforms. Fisher & Paykel reported USD 1.51 billion in hospital hardware revenue for FY2026, up 18% year over year. Medium Flow Rate masks face the greatest overlap with these alternatives, making complementary respiratory portfolios important for Venturi mask manufacturers.

Other drivers and restraints analyzed in the detailed report include:

• Infection-Control Preference for Single-Patient and Disposable Products
• Hospital and Emergency-Care Respiratory Capacity Expansion

Segment Analysis

Adult Venturi Masks held 65.31% of product-type demand in 2025, reflecting the large adult patient base for COPD, pneumonia, and post-surgical hypoxemia. Adult care settings use controlled oxygen therapy across wards, emergency departments, and critical care units. Pediatric Venturi Masks serve a smaller, stable segment that is supported by specialized hospitals and public-health procurement. UNICEF maintains specifications for adult single-use Venturi mask products, and comparable requirements guide pediatric purchasing decisions. Multi-Venturi Masks and Single Venturi Masks comprised the remainder of the product base. Fixed-concentration systems remain useful where staff already know the color-coded valve format and inventories are established. The Venturi masks market retains demand for these formats because they provide a familiar method of delivering set oxygen concentrations. Hospital purchasing teams must still manage separate stock-keeping units when they select several fixed-concentration products. This need adds storage and ordering work across high-volume respiratory units. Suppliers that retain fixed-format lines can therefore protect established accounts while offering a migration path to adjustable systems.

Adjustable Flow Venturi Masks are forecast to expand at 8.58% CAGR from 2026 to 2031, the highest rate in the product category. A single adjustable kit can replace several single-diluter products, reducing the number of items that a ward needs to hold. Intersurgical markets MultiOx and Silente adjustable Venturi products that illustrate this multiple-concentration approach. Clear calibration can simplify staff training and reduce selection errors when patients need different oxygen concentrations. A 2025 study in the Chinese Journal of Nursing examined differences in Venturi-mask output flow across humidification configurations. The finding supports attention to flow verification, particularly where humidification arrangements differ at the bedside. Adjustable formats may offer procurement value when hospital networks standardize products across multiple sites. They also create opportunities for suppliers to bundle masks with tubing, connectors, and oxygen-delivery accessories. This product shift does not eliminate demand for fixed valves, but it raises the value of portfolio breadth. The Venturi masks industry is consequently placing greater emphasis on simple, calibrated systems that reduce stock complexity.

Polyvinyl Chloride held 72.24% of material demand in 2025, making it the leading input in the material segment. PVC has established manufacturing supply chains and works with common respiratory tubing and connector systems. Its low input cost supports high-volume single-use products supplied through hospitals and distributors. Asian manufacturing facilities have developed large-scale production capabilities for this material format. PVC products also remain familiar to clinical purchasers that require standard disposable respiratory products. Rubber and other materials hold a smaller position because they do not match silicone on all patient-contact and durability considerations. Established tooling and supplier relationships further reinforce PVC use in existing mask designs. The material remains important because buyers continue to prioritize availability, compatibility, and unit cost. Any shift away from PVC must account for production capacity as well as regulatory requirements. This creates a gradual transition instead of a rapid replacement of conventional disposable products.

Silicone is forecast to grow at 8.22% CAGR from 2026 to 2031, making it the fastest-growing material type. The EU Medical Device Regulation requires special justification and labeling in cases involving certain CMR substances above 0.1% by weight. Phthalate plasticizers such as DEHP have therefore become a product-design consideration for manufacturers selling into Europe. ISO 10993 testing is also relevant to the assessment of materials used in patient-contact devices. Intersurgical’s EcoLite non-PVC mask body illustrates a response to the need for alternative material options within respiratory products. Scandinavian and German hospital groups can give added weight to non-DEHP specifications in procurement reviews. That preference may influence global specifications when multinational suppliers seek common product platforms. Silicone offers suppliers a route to differentiate through material choice, patient contact, and regulatory documentation. Demand for silicone-supported formats is therefore positioned to increase faster than the overall Venturi masks market. PVC will remain the material base, while silicone and non-PVC designs serve an expanding compliance-oriented requirement.

Complete Report Scope:

• By Product Type
  • Single Venturi Masks
  • Multi-Venturi Masks
  • Adjustable Flow Venturi Masks
  • Pediatric Venturi Masks
  • Adult Venturi Masks
• By Material Type
  • Polyvinyl Chloride
  • Silicone
  • Rubber
  • Other Material Types
• By Oxygen Flow Rate
  • Low Flow Rate, 1-6 L/min
  • Medium Flow Rate, 6-12 L/min
  • High Flow Rate, 12-15 L/min
  • Others
• By Application
  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Pneumonia
  • Myocardial Infarction
  • Respiratory Distress Syndrome
  • Aerosol Therapy
  • Other Applications
• By End User
  • Hospitals and Clinics
  • Homecare Settings
  • Ambulatory Surgery Centers
  • Other End Users
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 38.61% of demand in 2025, the largest regional position in the Venturi masks market. The region benefits from established hospital procurement systems and a large installed base of critical-care and emergency facilities. The United States accounted for most regional demand, while Canada and Mexico added smaller but developing requirements. Hospital expansions support recurring consumption of respiratory products after new capacity becomes operational. Northwestern Memorial Hospital’s approved USD 95.5 million project adds 42 beds in Chicago. Saskatchewan’s CAD 17 million (~USD 12 million) ICU project, expands the Royal University Hospital ICU from 19 to 26 beds. FDA device requirements and CMS reimbursement rules influence product documentation and commercial terms in the United States. These conditions support a mature market where purchasing decisions focus on quality, supply reliability, and contract value.

Asia-Pacific is projected to grow at 10.25% CAGR from 2026 to 2031, the fastest regional rate. Hospital capacity growth, increasing domestic production, and developing homecare models contribute to the regional outlook. India’s medical-device production incentives support efforts to reduce dependency on imported respiratory consumables. Polymedicure launched 35 new products in FY2026 and maintained an R&D team of 90 people across India, Italy, and the Netherlands, according to its August 2025 investor presentation. Japan and South Korea sustain demand for premium respiratory products through aging populations and high healthcare spending. Regional hospitals are also adding capacity for emergency and critical-care services. The Venturi masks market benefits when new hospitals adopt centralized oxygen-delivery infrastructure and standardized consumable inventories. Domestic manufacturers can compete on supply responsiveness and cost, while international suppliers can focus on advanced materials and adjustable products. This mix can narrow the difference between North America’s current size and Asia-Pacific’s future growth rate.

Europe remained the second-largest regional market, with Germany, the United Kingdom, France, Italy, and Spain as principal demand centers. EU medical-device rules are shaping procurement toward products with clearer material documentation and traceability. The United Kingdom’s oxygen guidance continues to support controlled oxygen therapy for patients at risk of hypercapnic respiratory failure. Scandinavian and German purchasing groups have particular relevance for non-DEHP and non-PVC alternatives. South America, led by Brazil and Argentina, has a smaller base but requires growing emergency-care capacity. The Middle East and Africa also begin from a smaller demand base, with GCC health infrastructure investment supporting respiratory-consumable procurement. Fiona Stanley Hospital’s 40-bed critical-care expansion in Australia illustrates the wider relevance of capacity additions in developed health systems. These regions offer growth opportunities where suppliers can meet tender requirements, local distribution needs, and material specifications.

List of Companies Covered in this Report:

• Airways Surgical Pvt. Ltd.
• Beckton Dickinson
• Besmed Health Business
• Dragerwerk
• Fisher & Paykel Healthcare Corporation Limited
• Flexicare
• For Care Enterprise Co. Ltd.
• GaleMed Corporation
• HSINER Co. Ltd.
• ICU Medical
• Intersurgical Ltd.
• JG Moriya
• Medline Industries
• PFM medical AG
• Polymedicure Limited
• PVS S.p.A.
• SunMed
• Teleflex
• Terumo
• Zoll Medical

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support